Sangamo Therapeutics
SGMO
#10512
Rank
โ‚ฌ18.16 M
Marketcap
0,04383ย โ‚ฌ
Share price
0.00%
Change (1 day)
-90.48%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚ฌ18.16 Million

As of June 2026 Sangamo Therapeutics has a market cap of โ‚ฌ18.16 Million. This makes Sangamo Therapeutics the world's 10512th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ18.16 M-85.08%
2025โ‚ฌ0.12 B-76.28%
2024โ‚ฌ0.51 B488.9%
2023โ‚ฌ87.16 M-81.83%
2022โ‚ฌ0.47 B-50.27%
2021โ‚ฌ0.96 B-46.24%
2020โ‚ฌ1.79 B107.09%
2019โ‚ฌ0.86 B-15.5%
2018โ‚ฌ1.02 B-11.24%
2017โ‚ฌ1.15 B464.13%
2016โ‚ฌ0.20 B-65.14%
2015โ‚ฌ0.58 B-31.98%
2014โ‚ฌ0.86 B37.96%
2013โ‚ฌ0.62 B159.69%
2012โ‚ฌ0.24 B110.08%
2011โ‚ฌ0.11 B-49.34%
2010โ‚ฌ0.22 B21.84%
2009โ‚ฌ0.18 B82.26%
2008โ‚ฌ0.10 B-71.63%
2007โ‚ฌ0.35 B105.1%
2006โ‚ฌ0.17 B68.55%
2005โ‚ฌ0.10 B-6.96%
2004โ‚ฌ0.11 B3.1%
2003โ‚ฌ0.10 B52.19%
2002โ‚ฌ71.23 M-72.49%
2001โ‚ฌ0.25 B-43.52%
2000โ‚ฌ0.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ537.43 B 2,959,293.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ169.54 B 933,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ27.96 B 153,870.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ18.34 B 100,942.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ139.19 B 766,379.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ278.58 B 1,533,938.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ34.10 B 187,699.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.99 B 54,952.32%๐Ÿ‡บ๐Ÿ‡ธ USA